Redx Pharma previews plans for idiopathic pulmonary fibrosis and Crohn's disease
CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.
Stay updated with breaking news from Drug Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.
According to the Alzheimer’s association, in 2022 approximately 6.5 million Americans are living with Alzheimer’s disease.
CNS Pharmaceuticals has dosed the first subject in France in the trial analysing Berubicin to treat recurrent glioblastoma multiforme.
Chronic obstructive pulmonary disease is a group of progressive chronic inflammatory lung conditions that cause breathing difficulties.
We analyse the impact of the war on the clinical trial landscapes of Ukraine and Russia, as investigators chronicle the situation on the ground.